Family · Pharmaceutical analytical standards
Roxadustat
An oral HIF prolyl hydroxylase inhibitor: it makes the body believe it is short of oxygen, so the kidneys produce more erythropoietin. It is used for anaemia of chronic kidney disease. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?China was the first country in the world to approve it, in December 2018: it was the first oral drug of its class authorised for anaemia of chronic kidney disease.
No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
